Our strategy is to change 250 million lives in 2025. We're proud to make equipment and connected health solutions that give those with sleep apnoea, COPD and other respiratory diseases the gift of breath.

Aims and objectives

Our aim is to deliver life-changing products and connected health solutions to patients worldwide with sleep apnoea or other respiratory conditions, and to spread awareness about these conditions and treatments. Our objective is two-fold:

1. Provide life-changing diagnoses and treatments to patients with sleep apnoea, COPD and other respiratory diseases; and
2. Enable remote and self-monitoring via our therapy devices to improve patients’ experiences, outcomes and health, as well as clinicians’ patient management efficiency.

We sell a comprehensive range of products in more than 140 countries worldwide through direct offices and a network of distributors. Plus nearly 20.5 million ResMed devices are cloud-connected, sharing actionable data with clinicians and patients themselves to improve their therapy experience, adherence, and overall health.

Dedicating 7-8% of annual revenue to research and development, we are committed to advancing innovative technology in sleep and respiratory medicine, to commercialising innovative products that incorporate these technologies around the world, and exercising the highest standards of ethics and quality at all times.